Lorazepam Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Lorazepam Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Sep 5, 2018. Reported reason: Other

Shortage details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0641-6002-10
Dosage Form
Injection
Presentation
Ativan, Injection, 4 mg/1 mL (NDC 0641-6002-10)
Initial Posting
Sep 5, 2018

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.